Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.160
-0.010 (-0.85%)
Dec 5, 2025, 4:00 PM EST - Market closed
Mainz Biomed Stock Forecast
MYNZ's stock price has decreased by -84.15% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Mainz Biomed stock has a target of 14, which predicts a 1,106.90% increase from the current stock price of 1.16.
Price Target: $14 (+1,106.90%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 14, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Mainz Biomed is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +1,106.90% | Feb 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $120 | Strong Buy | Maintains | $200 → $120 | +10,244.83% | Mar 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2023 |
Financial Forecast
Revenue This Year
891.48K
from 893.99K
Decreased by -0.28%
Revenue Next Year
936.36K
from 891.48K
Increased by 5.03%
EPS This Year
-2.92
from -22.36
EPS Next Year
-1.38
from -2.92
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 917,700 | 963,900 | ||||
| Avg | 891,480 | 936,360 | ||||
| Low | 856,520 | 899,640 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.7% | 8.1% | ||||
| Avg | -0.3% | 5.0% | ||||
| Low | -4.2% | 0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -3.00 | -1.42 | |
| Avg | -2.92 | -1.38 | |
| Low | -2.80 | -1.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.